Baird Medical Investment HolBDMD

13F holders, Q3 2025 (September 30)
8holders −2
2new positions
4sold out
1famous investor
$2.08avg. 13F price*

At the end of Q3 2025, 8 institutions reported holding Baird Medical Investment Hol (BDMD) in their 13F filings, down 2 from Q2 2025. 2 opened new positions and 4 sold out. The largest holders were Highbridge Capital Management LLC ($265K), Periscope Capital Inc. ($245K) and UBS Group AG ($140K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Baird Medical Investment Hol
CUSIP
G0705H103
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q4 2024: 6Q4 2024Q1 2025: 6Q1 2025Q2 2025: 10Q2 2025Q3 2025: 8Q3 2025Q4 2025: 8Q4 2025Q1 2026: 8Q1 2026Q2 2026: 10Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions2$99K
Exits4$339K

All 13F filers, Q2 2025 → Q3 2025: 46,737 shares bought and 134,586 shares sold, net −87,849 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Highbridge Capital Management LLC 0.04% No change 125,000 $265K
Periscope Capital Inc. 0.06% No change 125,000 $245K
UBS Group AG 0.00% Reduce -28.0% 65,818 $140K
Northern Trust Corp. 0.00% Reduce -7.9% 48,288 $102K
Citadel Advisors 0.00% New 46,532 $99K
Geode Capital Management, LLC 0.00% No change 25,442 $54K
Virtu Financial LLC 0.00% Reduce -46.7% 14,039 $30K
Wolverine Asset Management LLC 0.00% New 205 $434

"% of holder's portfolio" is BDMD's weight in each manager's 13F, not the share of Baird Medical Investment Hol the manager owns.